A look at the shareholders of EC Healthcare (HKG:2138) can tell us which group is most powerful. With 62% stake, individual insiders possess the maximum shares in the company. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).
It's interesting to note that insiders have been buying shares recently. Their expectations, however, were not satisfied, as the market cap dropped to HK$6.0b over the past week.
Let's take a closer look to see what the different types of shareholders can tell us about EC Healthcare.
View our latest analysis for EC Healthcare
SEHK:2138 Ownership Breakdown September 20th 2022
What Does The Institutional Ownership Tell Us About EC Healthcare?
Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.
We can see that EC Healthcare does have institutional investors; and they hold a good portion of the company's stock. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of EC Healthcare, (below). Of course, keep in mind that there are other factors to consider, too.
SEHK:2138 Earnings and Revenue Growth September 20th 2022
Hedge funds don't have many shares in EC Healthcare. Looking at our data, we can see that the largest shareholder is the CEO Chi Fai Tang with 61% of shares outstanding. This essentially means that they have significant control over the outcome or future of the company, which is why insider ownership is usually looked upon favourably by prospective buyers. For context, the second largest shareholder holds about 4.3% of the shares outstanding, followed by an ownership of 4.0% by the third-largest shareholder.
While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. There are a reasonable number of analysts covering the stock, so it might be useful to find out their aggregate view on the future.
Insider Ownership Of EC Healthcare
The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.
I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.
Our information suggests that insiders own more than half of EC Healthcare. This gives them effective control of the company. Given it has a market cap of HK$6.0b, that means they have HK$3.7b worth of shares. Most would argue this is a positive, showing strong alignment with shareholders. You can click here to see if those insiders have been buying or selling.
General Public Ownership
The general public, who are usually individual investors, hold a 22% stake in EC Healthcare. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.
Next Steps:
While it is well worth considering the different groups that own a company, there are other factors that are even more important.
I like to dive deeper into how a company has performed in the past. You can find historic revenue and earnings in this detailed graph.
If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
看看EC Healthcare(HKG:2138)的股东可以告诉我们哪个集团最有权势。个人内部人士持有该公司62%的股份,拥有该公司的最大股份。也就是说,如果股价上涨,该集团将受益最大(如果股价下跌,该集团将损失最大)。
有趣的是,内部人士最近一直在买入股票。然而,随着市值在过去一周跌至60亿港元,他们的预期并未得到满足。
让我们仔细看看不同类型的股东能告诉我们关于EC Healthcare的什么。
查看我们对EC Healthcare的最新分析
联交所:2138拥有权分类2022年9月20日
关于EC Healthcare,机构所有权告诉了我们什么?
许多机构以一个接近当地市场的指数来衡量它们的表现。因此,他们通常更关注那些被纳入主要指数的公司。
我们可以看到,EC Healthcare确实有机构投资者;他们持有公司很大一部分股票。这意味着为这些机构工作的分析师已经看过了这只股票,他们喜欢它。但就像其他人一样,他们也可能错了。如果两个大型机构投资者试图同时抛售一只股票,股价大幅下跌的情况并不少见。因此,值得查看EC Healthcare过去的收益轨迹(见下图)。当然,请记住,还有其他因素需要考虑。
联交所:2138盈利及收入增长2022年9月20日
对冲基金在EC Healthcare的股份并不多。看看我们的数据,我们可以看到,第一大股东是拥有61%流通股的CEO迟辉堂。这本质上意味着他们对公司的结果或未来拥有重大控制权,这就是为什么内部人所有权通常被潜在买家看好的原因。作为参考,第二大股东持有约4.3%的流通股,第三大股东持有4.0%的股份。
虽然研究一家公司的机构持股可以增加你的研究价值,但研究分析师的建议以更深入地了解一只股票的预期表现也是一个很好的做法。有相当数量的分析师追踪该股,因此了解他们对未来的总体看法可能是有用的。
EC Healthcare的内部人所有权
不同国家对内部人的定义可能略有不同,但董事会成员总是算数的。公司管理层管理企业,但首席执行官将向董事会负责,即使他或她是董事会成员。
我通常认为内部人持股是一件好事。然而,在某些情况下,这会让其他股东更难让董事会对决策负责。
我们的信息表明,内部人士拥有EC Healthcare一半以上的股份。这让他们有效地控制了公司。鉴于其市值为60亿港元,这意味着他们拥有价值37亿港元的股票。大多数人会辩称,这是积极的,表明了与股东的强烈一致。你可以点击这里,看看这些内部人士是一直在买入还是卖出。
一般公有制
公众通常是个人投资者,他们持有EC Healthcare 22%的股份。尽管这种规模的所有权可能不足以影响有利于他们的政策决定,但他们仍然可以对公司政策产生集体影响。
接下来的步骤:
虽然考虑拥有一家公司的不同集团是很值得的,但还有其他更重要的因素。
我喜欢潜入更深的地方了解一家公司过去的表现。您可以在其中找到历史上的收入和收益详细图表.
如果你像我一样,你可能会想一想这家公司是会增长还是会萎缩。幸运的是,您可以查看这份显示分析师对其未来预测的免费报告。
注:本文中的数字是使用过去12个月的数据计算的,指的是截至财务报表日期的最后一个月的12个月期间。这可能与全年的年度报告数字不一致。
对这篇文章有什么反馈吗?担心内容吗? 保持联系直接与我们联系。或者,也可以给编辑组发电子邮件,地址是implywallst.com。
本文由Simply Wall St.撰写,具有概括性。我们仅使用不偏不倚的方法提供基于历史数据和分析师预测的评论,我们的文章并不打算作为财务建议。它不构成买卖任何股票的建议,也没有考虑你的目标或你的财务状况。我们的目标是为您带来由基本面数据驱动的长期重点分析。请注意,我们的分析可能不会将最新的对价格敏感的公司公告或定性材料考虑在内。Simply Wall St.对上述任何一只股票都没有持仓。